BIOMAT Database Logo BIOMAT Database Logo

[Plasma half life of a new cephalosporin in uremic patients]. 1973

J P Fillastre, and G Humbert, and H Malandain, and D Dubois, and M F Daufresne, and M Robert

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014511 Uremia A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms. Uremias

Related Publications

J P Fillastre, and G Humbert, and H Malandain, and D Dubois, and M F Daufresne, and M Robert
Cephalosporin-induced encephalopathy in uremic patients.
January 1988, Nephron,
J P Fillastre, and G Humbert, and H Malandain, and D Dubois, and M F Daufresne, and M Robert
Pharmacokinetics of Rocephin, a highly active new cephalosporin with an exceptionally long biological half-life.
January 1981, Chemotherapy,
J P Fillastre, and G Humbert, and H Malandain, and D Dubois, and M F Daufresne, and M Robert
Extended half-life, second-generation cephalosporin in surgical prophylaxis.
November 1985, Drug intelligence & clinical pharmacy,
J P Fillastre, and G Humbert, and H Malandain, and D Dubois, and M F Daufresne, and M Robert
Plasma half-life of DDAVP in uraemic patients.
October 1986, Acta pharmacologica et toxicologica,
J P Fillastre, and G Humbert, and H Malandain, and D Dubois, and M F Daufresne, and M Robert
Extremely prolonged half-life of prostacyclin in plasma causative for bleeding in an uremic patient?
January 1991, Nephron,
J P Fillastre, and G Humbert, and H Malandain, and D Dubois, and M F Daufresne, and M Robert
[Hemorrhage caused by cephalosporin antibiotics in uremic patients].
October 1987, Orvosi hetilap,
J P Fillastre, and G Humbert, and H Malandain, and D Dubois, and M F Daufresne, and M Robert
Plasma terminal half-life.
December 2004, Journal of veterinary pharmacology and therapeutics,
J P Fillastre, and G Humbert, and H Malandain, and D Dubois, and M F Daufresne, and M Robert
Half-life of plasma cholinesterase.
April 1988, Acta anaesthesiologica Scandinavica,
J P Fillastre, and G Humbert, and H Malandain, and D Dubois, and M F Daufresne, and M Robert
Ceftriaxone: a beta-lactamase-stable, broad-spectrum cephalosporin with an extended half-life.
January 1985, Pharmacotherapy,
J P Fillastre, and G Humbert, and H Malandain, and D Dubois, and M F Daufresne, and M Robert
The"half-and-half nail": a uremic onychopathy.
April 1972, Archives of dermatology,
Copied contents to your clipboard!